Clinical and genetic study of spinal muscular atrophies in Oman

被引:2
|
作者
Koul, Roshan
Al Futaisi, Amna
Chacko, Alexander
Rao, Vasudev
Simsek, Mehmet
Muralitharan, Shanmugakonar
Ganguly, Shyam S.
Bayoumi, Riad
机构
[1] Sultan Qaboos Univ Hosp, Coll Med & Hlth Sci, Dept Child Hlth, Muscat, Oman
[2] Sultan Qaboos Univ Hosp, Coll Med & Hlth Sci, Dept Pathol, Muscat, Oman
[3] Sultan Qaboos Univ Hosp, Coll Med & Hlth Sci, Dept Biochem, Muscat, Oman
关键词
spinal muscular atrophy; genetics;
D O I
10.1177/0883073807306268
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
This article presents a retrospective study and a prospective study on spinal muscular atrophy in Oman. For the retrospective study, data were collected from neurophysiology records, from both inpatient and outpatient files. The prospective study was conducted on children as they presented to the hospital and was funded by Sultan Qaboos University. The patients of spinal muscular atrophy were classified into types I, II, and III based on their clinical features as per the International Spinal Muscular Atrophy Consortium classification. The incidence of spinal muscular atrophywas about I per 6000 live births. Spinal muscular atrophy type I formed 65% of the cases. Survival motor neuron deletion was seen in 70% of cases of all types of spinal muscular atrophy The deletion was 83% in spinal muscular atrophy type I. A further study to look into the nondeletional cases is in progress.
引用
收藏
页码:1227 / 1230
页数:4
相关论文
共 50 条
  • [41] Clinical and molecular characterization of non-5q spinal muscular atrophies
    Calligaris, S.
    Guzman, A.
    Savransky, A.
    Buompadre, C.
    Lubieniecki, F.
    Rocha, C. Tesi
    Tiziano, D.
    Fano, V.
    Tizzano, E.
    Gravina, P.
    Monges, S.
    [J]. NEUROMUSCULAR DISORDERS, 2018, 28 : S57 - S57
  • [42] Cardiac involvement in patients with spinal muscular atrophies
    Palladino, A.
    Passamano, L.
    Scutifero, M.
    Di Gregorio, M. G.
    Spina, F.
    Torre, V.
    De Luca, F.
    Nigro, G.
    Politano, L.
    [J]. NEUROMUSCULAR DISORDERS, 2011, 21 (9-10) : 684 - 684
  • [43] Spinal muscular atrophies - distinctions and therapeutic progress
    Davies, SL
    Moral, MA
    [J]. DRUGS OF THE FUTURE, 2006, 31 (04) : 365 - 371
  • [44] MAPPING THE DISEASE LOCUS FOR THE SPINAL MUSCULAR ATROPHIES
    KLEYN, PW
    BRZUSTOWICZ, LM
    LEHNER, T
    LIEN, LL
    BOYCE, FM
    MILLER, JM
    MCPHERSON, J
    THOMPSON, T
    WASMUTH, JJ
    MUNSAT, TL
    KUNKEL, LM
    OTT, J
    GILLIAM, TC
    [J]. AMERICAN JOURNAL OF HUMAN GENETICS, 1991, 49 (04) : 346 - 346
  • [45] LOCALIZED BENIGN FORMS OF SPINAL MUSCULAR ATROPHIES
    LAVRIC, A
    TRONTELJ, JV
    FAGANEL, J
    JANKO, M
    [J]. ZDRAVSTVENI VESTNIK, 1980, 49 (01): : 27 - 30
  • [46] Consensus paper:: Diagnosis of spinal muscular atrophies
    Borasio, D
    Enders, A
    Hecht, M
    Kress, W
    Metzner, R
    Reiners, K
    Rudnik-Schöneborn, S
    Zerres, K
    [J]. NERVENHEILKUNDE, 2001, 20 (02) : 113 - 118
  • [47] Molecular Therapeutic Strategies for Spinal Muscular Atrophies: Current and Future Clinical Trials
    Zanetta, Chiara
    Nizzardo, Monica
    Simone, Chiara
    Monguzzi, Erika
    Bresolin, Nereo
    Comi, Giacomo P.
    Corti, Stefania
    [J]. CLINICAL THERAPEUTICS, 2014, 36 (01) : 128 - 140
  • [48] SENSORY NERVE-CONDUCTION IN SPINAL MUSCULAR ATROPHIES
    SCHWARTZ, MS
    MOOSA, A
    [J]. DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY, 1977, 19 (01): : 50 - 53
  • [49] LINKAGE AND APPARENT HETEROGENEITY IN PROXIMAL SPINAL MUSCULAR ATROPHIES
    COBBEN, JM
    SCHEFFER, H
    DEVISSER, M
    OSINGA, J
    FRANTS, R
    VANDERSTEEGE, G
    WIJMENGA, C
    TENKATE, LP
    VANOMMEN, GJB
    BUYS, CHCM
    [J]. NEUROMUSCULAR DISORDERS, 1993, 3 (04) : 327 - 333
  • [50] Nusinersen and Spinal Muscular Atrophies: Where are we in 2020?
    Khadilkar, Satish V.
    Singh, Rakesh K.
    [J]. ANNALS OF INDIAN ACADEMY OF NEUROLOGY, 2020, 23 (06) : 743 - 744